Literature DB >> 15180947

Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage.

Yi-Hsuan Hsieh1, Ih-Jen Su, Hui-Ching Wang, Wen-Wei Chang, Huan-Yao Lei, Ming-Derg Lai, Wen-Tsan Chang, Wenya Huang.   

Abstract

Ground glass hepatocytes (GGHs) are the historic hallmarks for the hepatocytes in the late and non-replicative stages of hepatitis B virus (HBV) infection. We have identified type I and type II GGHs that contain two mutant types of large HBV surface antigens (HBsAg) with deletions over the pre-S1 and pre-S2 regions, respectively. These pre-S mutant HBVsAg accumulate in endoplasmic reticulum (ER), resulting in strong ER stress. Type II GGHs often appear in hepatic nodules in the late phases of HBV infection and proliferate in clusters, suggesting that these mutant pre-S1/S2 HBsAg may be involved in HBV-related hepatocarcinogenesis, associated with ER stress. In this study, we investigated the potential genomic instability imposed by pre-S mutant HBsAg. Based on the analysis of comet assays, we found that the pre-S1 and pre-S2 mutant HBsAg caused oxidative stress and DNA damage. The DNA repair gene ogg1 was greatly induced by over-expression of pre-S mutant HBsAg. Induction of the DNA repair gene ogg1 was also detected in the pre-S2 HBsAg transgenic mice, as well as the type II GGHs from patients with hepatocellular carcinoma, strongly suggesting that the pre-S mutant HBsAg contributes to the oxidative DNA damage to hepatocytes. In addition, the mutation rates in the X-linked hprt gene were enhanced in mouse hepatoma ML1-4a cells, which constitutively expressed the pre-S1/S2 HBsAg. These results indicate that pre-S1/S2 mutant HBsAg, which make up GGHs, induce oxidative DNA damage and mutations in hepatocytes in the late stages of HBV infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15180947     DOI: 10.1093/carcin/bgh207

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  111 in total

1.  Male-specific W4P/R mutation in the pre-S1 region of hepatitis B virus, increasing the risk of progression of liver diseases in chronic patients.

Authors:  Seoung-Ae Lee; Ki-Jeong Kim; Dong-Won Kim; Bum-Joon Kim
Journal:  J Clin Microbiol       Date:  2013-09-11       Impact factor: 5.948

Review 2.  Oxidative stress and antioxidants in hepatic pathogenesis.

Authors:  Hye-Lin Ha; Hye-Jun Shin; Mark A Feitelson; Dae-Yeul Yu
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

Review 3.  Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis.

Authors:  Asmaa-Ibrahim Gomaa; Shahid-A Khan; Mireille-B Toledano; Imam Waked; Simon-D Taylor-Robinson
Journal:  World J Gastroenterol       Date:  2008-07-21       Impact factor: 5.742

Review 4.  Pre-S2 Mutant-Induced Mammalian Target of Rapamycin Signal Pathways as Potential Therapeutic Targets for Hepatitis B Virus-Associated Hepatocellular Carcinoma.

Authors:  Chiao-Fang Teng; Han-Chieh Wu; Woei-Cherng Shyu; Long-Bin Jeng; Ih-Jen Su
Journal:  Cell Transplant       Date:  2017-02-14       Impact factor: 4.064

Review 5.  Hepatitis B virus genotypes and variants.

Authors:  Chih-Lin Lin; Jia-Horng Kao
Journal:  Cold Spring Harb Perspect Med       Date:  2015-05-01       Impact factor: 6.915

6.  The degradation pathway for the HBV envelope proteins involves proteolysis prior to degradation via the cytosolic proteasome.

Authors:  Yuanjie Liu; Tianlun Zhou; Ender Simsek; Timothy Block; Anand Mehta
Journal:  Virology       Date:  2007-08-23       Impact factor: 3.616

7.  Zinc-dependent interaction between JAB1 and pre-S2 mutant large surface antigen of hepatitis B virus and its implications for viral hepatocarcinogenesis.

Authors:  Jye-Lin Hsu; Woei-Jer Chuang; Ih-Jen Su; Wen-Jun Gui; Yu-Ying Chang; Yun-Ping Lee; Yu-Lin Ai; David T Chuang; Wenya Huang
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

8.  Establishment and primary application of a mouse model with hepatitis B virus replication.

Authors:  Feng-Jun Liu; Li Liu; Fang He; Su Wang; Tao-You Zhou; Cong Liu; Lin-Yu Deng; Hong Tang
Journal:  World J Gastroenterol       Date:  2007-10-28       Impact factor: 5.742

9.  Tunicamycin induces resistance to camptothecin and etoposide in human hepatocellular carcinoma cells: role of cell-cycle arrest and GRP78.

Authors:  Jui-Ling Hsu; Po-Cheng Chiang; Jih-Hwa Guh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-11       Impact factor: 3.000

10.  Hepatitis B virus infection contributes to oxidative stress in a population exposed to aflatoxin B1 and high-risk for hepatocellular carcinoma.

Authors:  Zhi-Ming Liu; Le-Qun Li; Min-Hao Peng; Tang-Wei Liu; Zhong Qin; Ya Guo; Kai-Yin Xiao; Xin-Ping Ye; Xin-Shao Mo; Xue Qin; Shan Li; Lu-Nan Yan; Han-Ming Shen; LianWen Wang; Qiao Wang; Kai-bo Wang; Ren-xiang Liang; Zong-liang Wei; Choon Nam Ong; Regina M Santella; Tao Peng
Journal:  Cancer Lett       Date:  2008-02-15       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.